⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AMRN News
Amarin Corp Plc
Global Medical Device Contract Manufacturing Market is Predicted to Cross the USD 190 Billion Mark by 2032, Owing to the Rising Demand for Advanced Healthcare Solutions | DelveInsight
globenewswire.com
TMO
PFE
AMGN
BMY
MRK
DHR
ABBV
GOOG
MSFT
JNJ
MDT
BSX
SYK
EW
ISRG
EMR
BIOX
EXAS
QRVO
TER
ADI
TXN
ON
INTC
NVDA
AMD
HPQ
DELL
IBM
GE
FISV
ADP
PAYX
NOW
CRM
ORCL
SAP
ADSK
CDNS
SNPS
AMAT
INFY
HPE
LOGI
ATHM
BIIB
GILD
REGN
VRTX
AMRN
AZN
LLY
NVS
CRSP
EDIT
NTLA
ALNY
INCY
XRAY
COO
MASI
IRTC
MRNA
EMB
ADMA
ICUI
HOLX
LH
DGX
RDNT
EVTC
AFYA
CHKP
DDOG
SMCI
ALGN
THRY
PTC
MCHP
NXPI
QCOM
SWKS
MU
WDC
STX
International Superstar YOSHIKI Donates $100,000 for Thailand and Indonesia Flood Relief Immediately Following $100,000 Hong Kong Fire Disaster Donation
prnewswire.com
AMRN
L’épidémie silencieuse des allergies, l’urgence d’agir ! Un appel clair à accélérer la mobilisation nationale
businesswire.com
AMRN
Scott Air Force Base and Hunt Military Communities Achieve Major Energy Efficiency Milestone
businesswire.com
AMRN
SEVEN-TIME WORLD BBQ CHAMPION AND AWARD-WINNING CHEF MELISSA COOKSTON IGNITES HER MOST AMBITIOUS COOKBOOK YET
prnewswire.com
AMRN
NFLX
New REDUCE-IT® Aspirin Analysis Presented at AHA Scientific Sessions 2025 Reinforces VASCEPA®/VAZKEPA® (Icosapent Ethyl) Reduced Cardiovascular Events in High-Risk Patients
globenewswire.com
AMRN
Amarin To Present New Analyses Affirming Robustness of Data from REDUCE-IT and Additional Mechanisms of Action of Eicosapentaenoic Acid (EPA) at American Heart Association (AHA) Scientific Sessions 2025
globenewswire.com
AMRN
Amarin Reports Third Quarter 2025 Financial Results
globenewswire.com
AMRN
Amarin Issues Statement Supporting FDA’s Action to Revise Labeling for Fenofibrate Drugs Reinforcing a Lack of Cardiovascular Benefit
globenewswire.com
AMRN
Amarin to Report Third Quarter 2025 Financial Results and Host Conference Call on October 29, 2025
globenewswire.com
AMRN